1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
2
|
Li XY, Luo QF, Li J, Wei CK, Kong XJ,
Zhang JF and Fang L: Clinical significance of NOB1 expression in
breast infiltrating ductal carcinoma. Int J Clin Exp Pathol.
6:2137–2144. 2013.
|
3
|
Xu X, Tang X, Lu M, Tang Q, Zhang H, Zhu
H, Xu N, Zhang D, Xiong L, Mao Y and Zhu J: Overexpression of
MAGE-A9 predicts unfavorable outcome in breast cancer. Exp Mol
Pathol. 97:579–584. 2014. View Article : Google Scholar
|
4
|
Arnutti P, Kotepui M, Asanprakit W,
Punyarit P, Chavalitshewinkoon-Petmitr P, Harnroongroj T and
Petmitr S: Determination of whole transcription profiles and
specific pathways in invasive ductal breast carcinoma. Int J Clin
Exp Pathol. 6:1112–1120. 2013.
|
5
|
Parker JS, Mullins M, Cheang MC, Leung S,
Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al:
Supervised risk predictor of breast cancer based on intrinsic
subtypes. J Clin Oncol. 27:1160–1167. 2009. View Article : Google Scholar
|
6
|
Wang S, Li H, Wang J and Wang D:
Expression of microRNA-497 and its prognostic significance in human
breast cancer. Diagn Pathol. 8:1722013. View Article : Google Scholar
|
7
|
Kundra R and Kornfeld S: Asparagine-linked
oligosaccharides protect Lamp-1 and Lamp-2 from intracellular
proteolysis. J Biol Chem. 274:31039–31046. 1999. View Article : Google Scholar
|
8
|
Saftig P and Klumperman J: Lysosome
biogenesis and lysosomal membrane proteins: Trafficking meets
function. Nat Rev Mol Cell Biol. 10:623–635. 2009. View Article : Google Scholar
|
9
|
Parkinson-Lawrence EJ, Dean CJ, Chang M,
Hopwood JJ, Meikle PJ and Brooks DA: Immunochemical analysis of
CD107a (LAMP-1). Cell Immunol. 236:161–166. 2005. View Article : Google Scholar
|
10
|
Kannan K, Stewart RM, Bounds W, Carlsson
SR, Fukuda M, Betzing KW and Holcombe RF: Lysosome-associated
membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are
activation-dependent cell surface glycoproteins in human peripheral
blood mononuclear cells which mediate cell adhesion to vascular
endothelium. Cell Immunol. 171:10–19. 1996. View Article : Google Scholar
|
11
|
Andrejewski N, Punnonen EL, Guhde G,
Tanaka Y, Lüllmann-Rauch R, Hartmann D, von Figura K and Saftig P:
Normal lysosomal morphology and function in LAMP-1-deficient mice.
J Biol Chem. 274:12692–12701. 1999. View Article : Google Scholar
|
12
|
Sarafian V, Jadot M, Foidart JM, Letesson
JJ, Van den Brûle F, Castronovo V, Wattiaux R and Coninck SW:
Expression of Lamp-1 and Lamp-2 and their interactions with
galectin-3 in human tumor cells. Int J Cancer. 75:105–111. 1998.
View Article : Google Scholar
|
13
|
Sawada R, Jardine KA and Fukuda M: The
genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2.
5′-flanking sequence of lamp-2 gene and comparison of exon
organization in two genes. J Biol Chem. 268:9014–9022. 1993.
|
14
|
Furuta K, Ikeda M, Nakayama Y, Nakamura K,
Tanaka M, Hamasaki N, Himeno M, Hamilton SR and August JT:
Expression of lysosome-associated membrane proteins in human
colorectal neoplasms and inflammatory diseases. Am J Pathol.
159:449–455. 2001. View Article : Google Scholar
|
15
|
Saitoh O, Wang WC, Lotan R and Fukuda M:
Differential glycosylation and cell surface expression of lysosomal
membrane glycoproteins in sublines of a human colon cancer
exhibiting distinct metastatic potentials. J Biol Chem.
267:5700–5711. 1992.
|
16
|
Kunzli BM, Berberat PO, Zhu ZW, Martignoni
M, Kleeff J, Tempia-Caliera AA, Fukuda M, Zimmermann A, Friess H
and Büchler MW: Influences of the lysosomal associated membrane
proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on
the prognosis of pancreatic carcinoma. Cancer. 94:228–239. 2002.
View Article : Google Scholar
|
17
|
Lin H, Huang JF, Qiu JR, Zhang HL, Tang
XJ, Li H, Wang CJ, Wang ZC, Feng ZQ and Zhu J: Significantly
upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of
invasive ductal breast cancer. Exp Mol Pathol. 94:73–78. 2013.
View Article : Google Scholar
|
18
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar
|
19
|
Ni S, Xu L, Huang J, Feng J, Zhu H, Wang G
and Wang X: Increased ZO-1 expression predicts valuable prognosis
in non-small cell lung cancer. Int J Clin Exp Pathol. 6:2887–2895.
2013.
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
21
|
Han L, Jiang B, Wu H, Zhang S and Lu X:
Expression and prognostic value of MAGE-A9 in laryngeal squamous
cell carcinoma. Int J Clin Exp Pathol. 7:6734–6742. 2014.
|
22
|
Wang Q, Ni Q, Wang X, Zhu H, Wang Z and
Huang J: High expression of RAB27A and TP53 in pancreatic cancer
predicts poor survival. Med Oncol. 32:3722015. View Article : Google Scholar
|
23
|
Zhu H, Lu J, Wang X, Zhang H, Tang X, Zhu
J and Mao Y: Upregulated ZO-1 correlates with favorable survival of
gastrointestinal stromal tumor. Med Oncol. 30:6312013. View Article : Google Scholar
|
24
|
Huang J, Zhang J, Li H, Lu Z, Shan W,
Mercado-Uribe I and Liu J: VCAM1 expression correlated with
tumorigenesis and poor prognosis in high grade serous ovarian
cancer. Am J Transl Res. 5:336–346. 2013.
|
25
|
Groth-Pedersen L and Jäättelä M: Combating
apoptosis and multidrug resistant cancers by targeting lysosomes.
Cancer Lett. 332:265–274. 2013. View Article : Google Scholar
|
26
|
Jäättelä M: Multiple cell death pathways
as regulators of tumour initiation and progression. Oncogene.
23:2746–2756. 2004. View Article : Google Scholar
|
27
|
Kirkegaard T and Jäättelä M: Lysosomal
involvement in cell death and cancer. Biochim Biophys Acta.
1793:746–754. 2009. View Article : Google Scholar
|
28
|
Boya P and Kroemer G: Lysosomal membrane
permeabilization in cell death. Oncogene. 27:6434–6451. 2008.
View Article : Google Scholar
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar
|
30
|
Jensen SS, Aaberg-Jessen C, Christensen KG
and Kristensen B: Expression of the lysosomal-associated membrane
protein-1 (LAMP-1) in astrocytomas. Int J Clin Exp Pathol.
6:1294–1305. 2013.
|
31
|
Ozaki K, Nagata M, Suzuki M, Fujiwara T,
Ueda K, Miyoshi Y, Takahashi E and Nakamura Y: Isolation and
characterization of a novel human lung-specific gene homologous to
lysosomal membrane glycoproteins 1 and 2: Significantly increased
expression in cancers of various tissues. Cancer Res. 58:3499–3503.
1998.PubMed/NCBI
|
32
|
Krishnan V, Bane SM, Kawle PD, Naresh KN
and Kalraiya RD: Altered melanoma cell surface glycosylation
mediates organ specific adhesion and metastasis via lectin
receptors on the lung vascular endothelium. Clin Exp Metastasis.
22:11–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
33
|
Agarwal AK, Srinivasan N, Godbole R, More
SK, Budnar S, Gude RP and Kalraiya RD: Role of tumor cell surface
lysosome-associated membrane protein-1 (LAMP1) and its associated
carbohydrates in lung metastasis. J Cancer Res Clin Oncol.
141:1563–1574. 2015. View Article : Google Scholar : PubMed/NCBI
|